Table 1,0ccupational exposure limits
<br />for asbestos
<br />Exposure limits
<br />MWW*
<br />OSHA PEL TWA 0.2
<br />Action level 0.1
<br />NIOSH REL TWA (Ca)t 0.1
<br />ACGIH Tus TWA (Ala)§ 20
<br />Chrysotile 0.5
<br />Amosite 0.2
<br />Crocidolite 2.0
<br />Other forms
<br />* Fibers greater than 5 µm in length -a potent
<br />human car-
<br />t (Ca): NIOSH recommends treating po
<br />cinogen.
<br />§ (Ala): Human carcinogen with an assigned TLV®.
<br />HEALTH HAZARD INFORMATION
<br />• Routes of exposure
<br />Asbestos may cause adverse health effects following exposure
<br />via inhalation or ingestion.
<br />• Sumnvary of toxicology
<br />1 �ects on animals: Single intrapleural injections of asbestos
<br />in rats, rabbits, and hamsters produced mesothelioma (cancer
<br />of the chest or abdominal linings). In rats, chronic inhalation
<br />or oral administration of asbestos produced cancers of the
<br />All forms
<br />lungs, stomach, kidneys; liver, or mammary glands.
<br />of asbestos were found to be carcinogenic in treated animals.
<br />2. Effects on humans: Exposure to asbestos has been found to
<br />significantly increase the risks of contracting asbestosis, lung
<br />cancer, and mesothelioma.
<br />• Signs and symptoms of exposure
<br />1. Short-term (acute): Exposure to asbestos can cause short-
<br />ness of breath, chest or abdominal pain, and irritation of the
<br />skin and mucous membranes.
<br />2. Long-term (chronic): Exposure to asbestos can cause
<br />reduced pulmonary function, breathing difficulty, dry cough,
<br />broadening and thickening of the ends of the fingers, and bluish
<br />discoloration of the skin and mucous membranes.
<br />IA
<br />RECOMMENDED
<br />and biologic monitoring, medical screening, and morbidity and
<br />mortality data. This analysis may provide information about
<br />the relatedness of adverse health effects and occupational ex-
<br />posure that cannot be discerned from results in individual
<br />workers. Sensitivity, specificity, and predictive values of bio-
<br />logic monitoring and medical screening tests should be evalu-
<br />ated on an industrywide basis prior to application in any given
<br />worker group. Intrinsic to a surveillance program is the dis-
<br />semination of summary data to those who need to know, in-
<br />cluding employers, occupational health professionals,
<br />potentially exposed workers, and regulatory and public health
<br />agencies. •
<br />• Preplacement medical evaluation
<br />Prior to placing a worker in a job with a potential for exposure
<br />to asbestos, the physician should evaluate and document the
<br />workers baseline health status with thorough medical, environ-
<br />mental, and occupational histories, a physical examination, and
<br />physiologic and laboratory tests appropriate for the anticipat-
<br />ed occupational risks. These should concentrate on the func-
<br />tion and integrity of the respiratory system using the principles
<br />and methods recommended by NIOSH and the American
<br />Thoracic Society, (ATS).
<br />A preplacement medical evaluation is recommended in order
<br />to detect and assess preexisting or concurrent conditions which
<br />may be aggravated or result in increased risk when a worker
<br />is exposed to asbestos at or below the NIOSH REL. The ex-
<br />amining physician should consider the probable frequency, in-
<br />tensity,
<br />ntensity, and duration of exposure, as well as the nature and
<br />degree of the condition, in placing such a worker. Such con-
<br />ditions, which should not be regarded as absolute contraindi-
<br />cations to job placement, include cigarette smoking,
<br />preexisting asbestos-related disease, and significant breathing
<br />impairment due to preexisting chronic lung diseases. In addi-
<br />tion to the medical interview and physical examination, the
<br />means to identify these conditions may include the methods
<br />recommended by NIOSH and ATS.
<br />• Periodic medical screening and/or biologic monitoring
<br />Occupational health interviews and physical examinations
<br />should be performed at regular intervals. Additional examina-
<br />tions may be necessary should a worker develop symptoms that
<br />may be attributed to exposure to asbestos. The interviews. ex-
<br />• Medical surveillance Program at and appropriate medical screening and/or biologic
<br />ssive
<br />Workers with potential exposures tohazards o medicrveillance decrease or adverse trend in the Phys ologictng functioan n of the
<br />be monitored in a systemaatprogram
<br />and disease. respiratory system as compared to the baseline status of the in -
<br />intended to prevent or control occupational injury p values for a suitable refer -
<br />The program should include education of employers and work dividual worker or to the expected
<br />ers about work-related hazards, placement of workers in jobs ence population. The following testsshoouul d evale used ua-
<br />that do not jeopardize their safety and health, earliest possi- interpreted according to standardized procedures
<br />ble detection of adverse health effects, and referral of workers tion criteria recommended by NIOSH and ATS: standardized
<br />for diagnostic confirmation and treatment. The occurrence of questionnaires, tests of lung function, and chest X-rays.
<br />disease (a "sentinel health event, SHE) or other work-related
<br />adverse health effects should prompt immediate evaluation of
<br />primary preventive measures (e.g., industrial hygiene monitor-
<br />ing, engineering controls, and personal protective equipment).
<br />A medical surveillance program is intended to supplement, not
<br />replace, such measures.
<br />A medical surveillance program should include systematic col-
<br />lection and epidemiologic analysis of relevant environmental
<br />E
<br />® Medical practices recommended at the time of JUU h ans-
<br />fer or termination
<br />and occupational history inter -
<br />The medical, environmental,
<br />views, the physical examination, and selected physiologic and
<br />laboratory tests which were conducted at the time of placement
<br />should be repeated at the time of job transfer or termination.
<br />Any changes in the worker's health status should be compared
<br />to those expected for a suitable reference pop
<br />11
<br />
|